MedTrace Logo

Alcohol, Inflammation, and Mindfulness Study (AIM)

NCT02994043 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 182

Last updated 2023-01-19

Study results available
· View outcomes & findings →

Summary

The goal of the AIM Study is to examine the effectiveness of Mindfulness Based Relapse Prevention (MBRP) versus Relapse Prevention (RP) for the treatment of Alcohol Use Disorders (AUD) by implementing an 8-week long intervention and examining neurobiological, immunological, and epigenetic characteristics of AUD.

Conditions

Interventions

BEHAVIORAL

Mindfulness-Based Relapse Prevention Therapy

An 8-week, outpatient psychotherapy that combines mindfulness components with relapse prevention.

BEHAVIORAL

Relapse Prevention Therapy

An 8-week, outpatient psychotherapy that uses cognitive-behavioral components to reduce alcohol-related consequences.

Sponsors & Collaborators

  • University of Colorado, Boulder

    collaborator OTHER

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Ken Hutchison · University of Colorado Denver | Anschutz

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-09
Primary Completion
2021-02-17
Completion
2021-02-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02994043 on ClinicalTrials.gov